Compile Data Set for Download or QSAR
Report error Found 2872 Enz. Inhib. hit(s) with Target = 'Beta-1 adrenergic receptor'
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25746(cid_2685 | 2-hydroxy-5-{2-[(2-hydroxy-3-{4-[1-meth...)
Affinity DataKd:  1.60nMpH: 7.4 T: 2°CAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25748(ICI 89,406 | 3-(2-{[3-(2-cyanophenoxy)-2-hydroxypr...)
Affinity DataKd:  1.24nMpH: 7.4 T: 2°CAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25749(Practolol,(-) | Practolol,(+) | N-{4-[2-hydroxy-3-...)
Affinity DataKd:  724nMpH: 7.4 T: 2°CAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25750(N-(2-{[(2R)-2-hydroxy-3-(4-hydroxyphenoxy)propyl]a...)
Affinity DataKd:  60nMpH: 7.4 T: 2°CAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25751(Bisoprolol fumarate | Concor | [2-hydroxy-3-(4-{[2...)
Affinity DataKd:  15nMpH: 7.4 T: 2°CAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25752([(2S)-3-{4-[2-(cyclopropylmethoxy)ethyl]phenoxy}-2...)
Affinity DataKd:  6.20nMpH: 7.4 T: 2°CAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25753(Artrenolol | 2-{4-[2-hydroxy-3-(propan-2-ylamino)p...)
Affinity DataKd:  219nMpH: 7.4 T: 2°CAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25754(2-[4-(2-{[(2R)-2-hydroxy-3-phenoxypropyl]amino}eth...)
Affinity DataKd:  427nMpH: 7.4 T: 2°CAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25755(N-{3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propo...)
Affinity DataKd:  347nMpH: 7.4 T: 2°CAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25756(Betalok | Spesikor | {2-hydroxy-3-[4-(2-methoxyeth...)
Affinity DataKd:  55nMpH: 7.4 T: 2°CAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25747(4-[3-(tert-butylamino)-2-hydroxypropoxy]-2,3-dihyd...)
Affinity DataKd:  0.620nMpH: 7.4 T: 2°CAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25758(2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amin...)
Affinity DataKd:  23.5nMpH: 7.4 T: 2°CAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25759([3-(9H-carbazol-4-yloxy)-2-hydroxypropyl][2-(2-met...)
Affinity DataKd:  1.76nMpH: 7.4 T: 2°CAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25760(1-(naphthalen-2-yl)-2-(propan-2-ylamino)ethan-1-ol...)
Affinity DataKd:  363nMpH: 7.4 T: 2°CAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25761(Propanolol,(+/-) | PROPRANOLOL, l- | PROPRANOLOL,(...)
Affinity DataKd:  6.90nMpH: 7.4 T: 2°CAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25762(Sotalol,(-) | CHEMBL471 | cid_66245 | Sotalol,(+) ...)
Affinity DataKd:  1.70E+3nMpH: 7.4 T: 2°CAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25763(5-[(2R)-2-{[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl...)
Affinity DataKd: >1.00E+6nMpH: 7.4 T: 2°CAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25764(ALPRENOLOL,(-) | CHEMBL266195 | ALPRENOLOL,(+) | A...)
Affinity DataKd:  15nMpH: 7.4 T: 2°CAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25765(tert-butyl[3-(2-chloro-5-methylphenoxy)-2-hydroxyp...)
Affinity DataKd:  3.10nMpH: 7.4 T: 2°CAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25766(Corgard | (2R,3S)-5-[3-(tert-butylamino)-2-hydroxy...)
Affinity DataKd:  59nMpH: 7.4 T: 2°CAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25767(tert-butyl(2-hydroxy-3-{[4-(morpholin-4-yl)-1,2,5-...)
Affinity DataKd:  5.35nMpH: 7.4 T: 2°CAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25768(ICI 118,551 | 1-[(7-methyl-2,3-dihydro-1H-inden-4-...)
Affinity DataKd:  302nMpH: 7.4 T: 2°CAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25769(Levalbuterol | Salbutamol,(+/-) | albuterol | Prov...)
Affinity DataKd:  2.19E+4nMpH: 7.4 T: 2°CAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25770(Terbutaline,(+/-) | Brethine | 5-[2-(tert-butylami...)
Affinity DataKd:  1.51E+5nMpH: 7.4 T: 2°CAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25771(salmeterol xinafoate | 4-(1-hydroxy-2-{[6-(4-pheny...)
Affinity DataKd:  4.17E+3nMpH: 7.4 T: 2°CAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM485865(US10947196, Compound 03-1)
Affinity DataEC50: >1.00E+3nMAssay Description:Compound preparation. Candidate beta-adrenergic compounds, dissolved to 10 mM in DMSO, were diluted in 1× stimulation buffer 1 (Cisbio Part #64SB1FDD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM485866(US10947196, Compound 03-2)
Affinity DataEC50: >1.00E+3nMAssay Description:Compound preparation. Candidate beta-adrenergic compounds, dissolved to 10 mM in DMSO, were diluted in 1× stimulation buffer 1 (Cisbio Part #64SB1FDD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM485867(US10947196, Compound 03-3)
Affinity DataEC50:  55nMAssay Description:Compound preparation. Candidate beta-adrenergic compounds, dissolved to 10 mM in DMSO, were diluted in 1× stimulation buffer 1 (Cisbio Part #64SB1FDD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM485956(US10947196, Compound 03-4)
Affinity DataEC50: >1.00E+3nMAssay Description:Compound preparation. Candidate beta-adrenergic compounds, dissolved to 10 mM in DMSO, were diluted in 1× stimulation buffer 1 (Cisbio Part #64SB1FDD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent

TargetBeta-1 adrenergic receptor(Guinea pig)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50007476(CHEMBL266619 | 4-(3-tert-Butylamino-2-hydroxy-prop...)
Affinity DataEC50:  4.70nMAssay Description:Agonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atriaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Guinea pig)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50007478(CHEMBL10494 | 4-(3-tert-Butylamino-2-hydroxy-propo...)
Affinity DataEC50:  175nMAssay Description:Agonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atriaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Guinea pig)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM25392(Isoproterenol,(+) | CHEMBL434 | 4-[1-hydroxy-2-(pr...)
Affinity DataEC50:  6nMAssay Description:Agonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atriaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Guinea pig)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50007477(CHEMBL10453 | 4-(3-tert-Butylamino-2-hydroxy-propo...)
Affinity DataEC50:  8.60nMAssay Description:Agonistic activity (beta-1 adrenergic receptor) for the percent maximal increase in contraction rate of isolated guinea pig atriaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50108088(CHEMBL3601305)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at recombinant human beta1 adrenergic receptor expressed in CHO cells assessed as accumulation of cyclic AMP after 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/11/2020
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50265528(CHEMBL4089669)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at recombinant human beta1 adrenergic receptor expressed in CHO cells assessed as accumulation of cyclic AMP after 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/11/2020
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25392(Isoproterenol,(+) | CHEMBL434 | 4-[1-hydroxy-2-(pr...)
Affinity DataEC50:  3.20nMAssay Description:Agonist activity at recombinant human beta1 adrenergic receptor expressed in CHO cells assessed as accumulation of cyclic AMP after 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/11/2020
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50265530(CHEMBL4067502)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at recombinant human beta1 adrenergic receptor expressed in CHO cells assessed as accumulation of cyclic AMP after 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/11/2020
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50462277(CHEMBL4238084)
Affinity DataEC50:  889nMAssay Description:Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50462281(CHEMBL4245391)
Affinity DataEC50:  15nMAssay Description:Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50462282(CHEMBL4249564)
Affinity DataEC50:  2.90nMAssay Description:Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50462291(CHEMBL4248093)
Affinity DataEC50:  299nMAssay Description:Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50462284(CHEMBL4248727)
Affinity DataEC50:  426nMAssay Description:Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50462285(CHEMBL4241176)
Affinity DataEC50:  224nMAssay Description:Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50462302(CHEMBL4250215)
Affinity DataEC50:  124nMAssay Description:Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50462289(CHEMBL4245968)
Affinity DataEC50:  37nMAssay Description:Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50462292(CHEMBL4246134)
Affinity DataEC50:  1.00E+5nMAssay Description:Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50462280(CHEMBL4244929)
Affinity DataEC50:  6.20E+3nMAssay Description:Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50462293(CHEMBL4237802)
Affinity DataEC50:  1.27E+4nMAssay Description:Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50462294(CHEMBL4237453)
Affinity DataEC50:  36nMAssay Description:Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50462278(CHEMBL4241613)
Affinity DataEC50:  7.60nMAssay Description:Antagonist activity at human beta1 adrenergic receptor expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of isoproterenol-induc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
Displayed 1 to 50 (of 2872 total ) | Next | Last >>
Jump to: